“A Step Toward Progress”: Leading Almaty Physicians visited Israel
In June 2022 and following an invitation by Prof. Shimon Slavin, the Biotherapy International Clinic in Tel Aviv recently welcomed specialists from Kazakhstan: oncologist Daniyar Dzhumatayev, surgeon Askhat Ibambetov, and radiologist Ruslan Panov. The doctors that made up the delegation all practice in medical centers in Almaty, and have been cooperating with the clinic for…
Prof. Slavin and HepC Therapeutics are researching new viral-based treatments for COVID-19
Prof. Slavin is now serving as the medical director of HepC Therapeutics, Budapest, Hungary in partnership with ProBioGen, Berlin, Germany is now involved in clinical application of another poultry virus for treatment of COVID-19. This new virus, an attenuated infectious bursal disease virus (IBDV) for post-exposure treatment of patients infected with SARS-CoV-2 can be applied…
New medicinal product that harnesses the therapeutic potential of MSC-derived exosomes
After gaining clinical experience using bone marrow, placenta and cord tissue-derived mesenchymal stromal cells (MSCs), as well as the cumulative experience of more than 500 patients for over 10 years, we decided to investigate the potential therapeutic effects of MSCs’ excretory exosomes. These contain many of the therapeutic components that exist in MSCs, especially microRNAs,…
Prof. Slavin and his team have recently discovered a new oncolytic virus derived from chicken’s Newcastle disease virus (NDV)
Prof. Slavin and his team have recently discovered a new oncolytic virus derived from chicken’s Newcastle disease virus (NDV). NDV is dangerous for chickens but harmless in man. Different members of the large NDV family are already in clinical use for many years and the potential efficacy of NDV to control otherwise incurable brain cancer,…